Pfizer
Latest Iowa stories tagged “Pfizer”.
Fort Madison Daily Democrat
Pfizer Receives Positive CHMP Opinion for TALZENNA (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer
Southeast Iowa
•
Apr 26, 2019
Oelwein Daily Register
Pfizer Receives Positive CHMP Opinion for TALZENNA (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer
Northeast Iowa
•
Apr 26, 2019
Fort Madison Daily Democrat
Pfizer Hosts Annual Meeting of Shareholders
Southeast Iowa
•
Apr 25, 2019
Fort Madison Daily Democrat
Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis
Southeast Iowa
•
Apr 18, 2019
Oelwein Daily Register
Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis
Northeast Iowa
•
Apr 18, 2019
Fort Madison Daily Democrat
Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders
Southeast Iowa
•
Apr 18, 2019
Oelwein Daily Register
Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders
Northeast Iowa
•
Apr 18, 2019
Fort Madison Daily Democrat
Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive...
Southeast Iowa
•
Apr 13, 2019
Oelwein Daily Register
Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive...
Northeast Iowa
•
Apr 13, 2019
Fort Madison Daily Democrat
Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
Southeast Iowa
•
Apr 2, 2019
Oelwein Daily Register
Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
Northeast Iowa
•
Apr 2, 2019
Oelwein Daily Register
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
Northeast Iowa
•
Mar 20, 2019
Fort Madison Daily Democrat
U.S. FDA Approves Pfizer's Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin1
Southeast Iowa
•
Mar 12, 2019
Oelwein Daily Register
U.S. FDA Approves Pfizer's Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin1
Northeast Iowa
•
Mar 12, 2019
Oelwein Daily Register
Pfizer Receives Positive CHMP Opinion for LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer
Northeast Iowa
•
Mar 1, 2019
Keokuk Daily Gate City
Pfizer Receives Positive CHMP Opinion for LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer
Southeast Iowa
•
Mar 1, 2019
Fort Madison Daily Democrat
Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*
Southeast Iowa
•
Feb 19, 2019
Oelwein Daily Register
Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*
Northeast Iowa
•
Feb 19, 2019
Clinton Herald
Pfizer swings to loss due to restructuring, asset writedowns
Eastern Iowa
•
Jan 29, 2019